Patent · US Active

Methods for improvement of beta cell function with anti-IL-1β antibodies or fragments thereof

US8377429B2 · kind B2 · utility

3Cited by
30References
27Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 4, 2009
Grant dateFeb 19, 2013
Priority date—
Expiry dateSep 4, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/76
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are methods for improvement of beta cell function in a subject using an anti-IL-1β antibody or fragment thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.